SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $368,526 | +16.3% | 2,844 | -0.9% | 0.01% | 0.0% |
| Q3 2022 | $317,000 | -30.2% | 2,870 | -52.7% | 0.01% | -26.3% |
| Q2 2022 | $454,000 | -34.8% | 6,062 | -31.9% | 0.02% | -20.8% |
| Q1 2022 | $696,000 | -13.0% | 8,905 | +0.3% | 0.02% | -11.1% |
| Q4 2021 | $800,000 | -2.6% | 8,879 | 0.0% | 0.03% | -10.0% |
| Q3 2021 | $821,000 | +13583.3% | 8,879 | +22097.5% | 0.03% | – |
| Q2 2020 | $6,000 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |